Treating fatigue in patients with MS: one step forward, one step back.
Schwid
Steven R
SR
Murray
T Jock
TJ
D000547:Amantadine / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D018592:Cross-Over Studies; D015259:Dopamine Agents / Q000627:therapeutic use; D005221:Fatigue / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D000077408:Modafinil; D009103:Multiple Sclerosis / Q000150:complications* / Q000503:physiopathology; D010389:Pemoline / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D015259:Dopamine Agents; D010389:Pemoline; D000547:Amantadine; D001241:Aspirin; D000077408:Modafinil